India, April 7 -- SKF is consolidating its manufacturing footprint in the Americas as part of the ongoing separation of its Automotive business. The move is designed to strengthen long-term efficiency... Read More
Sri Lanka, April 7 -- Iranians have gathered in large numbers at bridges and power generation stations across the country, forming human chains to prevent them from being targeted, the country's state... Read More
New Delhi, April 7 -- New Delhi [India], April 07 : Adding to the string of academic triumphs, Ms. Haniya Khan, an MBA first semester student from IPS Academy, IBMR North Campus - a DAVV-affili... Read More
India, April 7 -- Mach Natural Resources LP (MNR) shares fell 10.24 percent, down $1.45 to $12.70 on Tuesday, after selling unitholders priced an underwritten public offering of 9 million common units... Read More
Singapore, April 7 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the po... Read More
Singapore, April 7 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507... Read More
Singapore, April 7 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemothera... Read More
Singapore, April 7 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safet... Read More
Singapore, April 7 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) M... Read More
Singapore, April 7 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig i... Read More